NCT07715227

Brief Summary

Brief Summary This randomized, double-blind, sham-controlled clinical trial is designed to investigate whether repeated sinusoidal galvanic vestibular stimulation (GVS) influences cardiac autonomic regulation in healthy adults during their routine occupational activities, and to determine whether these effects depend on subjective vestibular perception (dizziness) experienced during stimulation. The main questions it aims to answer are: Does repeated sinusoidal GVS alter heart rate variability (HRV) in healthy adults during their normal work activities? Do autonomic responses to GVS depend on the subjective intensity of dizziness experienced during stimulation? Does repeated GVS affect psycho-emotional well-being, including depressive and anxiety symptoms? Researchers will compare active GVS to sham stimulation to see if active stimulation produces measurable changes in cardiac autonomic regulation and whether these changes differ between participants reporting stronger versus minimal dizziness. Participants will undergo baseline assessment, complete four consecutive daily sessions of active or sham GVS, and undergo post-intervention assessment. Autonomic responses will be assessed using multiple HRV indices.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P50-P75 for not_applicable healthy-volunteers

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 30, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 13, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 13, 2022

Completed
4.2 years until next milestone

First Submitted

Initial submission to the registry

July 9, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 20, 2026

Completed
Last Updated

July 20, 2026

Status Verified

July 1, 2026

Enrollment Period

5 months

First QC Date

July 9, 2026

Last Update Submit

July 15, 2026

Conditions

Keywords

galvanic vestibular stimulationheart rate variabilityvestibulo-autonomic couplingvestibular perceptionautonomic regulationinteroceptionoccupational healthecological validity

Outcome Measures

Primary Outcomes (1)

  • Change in Heart Rate Variability (HRV) Indices from Baseline to Post-Course and During Acute Stimulation

    HRV will be assessed using complementary indices derived from continuous ambulatory ECG recordings (Polar H10) across multiple temporal scales: (1) course-level: baseline vs. post-course comparison; (2) acute: pre-stimulation, during stimulation, and post-stimulation epochs; (3) macro-scale: one-hour pre-stimulation vs. one-hour post-stimulation windows. Indices include time-domain (SDNN, mean RR intervals), frequency-domain (HFnu), nonlinear (SD1, SD2, SD2/SD1 ratio, DFA α1), and geometric (Baevsky Stress Index) measures.

    • Baseline (Day 1) • Days 2-5 (pre-stimulation, during 6-minute stimulation, immediately post-stimulation, and 1 hour post-stimulation) • Day 6 (post-course assessment)

Secondary Outcomes (5)

  • Autonomic Responses by Vestibular Perception Subgroups (High vs Low/No Dizziness)

    • Baseline (Day 1) • Days 2-5 (pre-stimulation, during 6-minute stimulation, immediately post-stimulation, and 1 hour post-stimulation) • Day 6 (post-course assessment)

  • Stimulation-Related Sensations and Tolerability

    • Days 2-5 (immediately after each stimulation session)

  • Changes in Psycho-Emotional Well-Being (Depressive Symptoms, Anxiety, and Affect)

    • Baseline (Day 1) • Day 6 (post-course assessment)

  • Blinding Integrity Assessment

    • Day 5 (immediately after the fourth stimulation session)

  • Change in Positive and Negative Affect as Measured by the PANAS

    • Days 2-5 (morning, pre-stimulation, post-stimulation, and end of workday)

Study Arms (2)

Active GVS

EXPERIMENTAL

Participants receive active sinusoidal galvanic vestibular stimulation (GVS) using the BrainPatch device. Stimulation parameters: 0.1 Hz sinusoidal waveform, peak current 0.62 mA, delivered for 6 minutes through bilateral electrodes placed over the mastoid processes. Participants remain seated with eyes closed while listening to relaxing meditative music. Stimulation is administered once daily for four consecutive days.

Device: Galvanic Vestibular Stimulation (GVS) using BrainPatch device

Sham GVS

SHAM COMPARATOR

An identical acoustic environment was created in the Sham group. To ensure effective blinding, participants in the Sham group received only one 10-second stimulation cycle at the beginning of the 6-minute session.

Device: Galvanic Vestibular Stimulation (GVS) using BrainPatch device

Interventions

Sinusoidal galvanic vestibular stimulation delivered via bilateral mastoid electrodes using the portable BrainPatch device. Stimulation parameters: 0.1 Hz sinusoidal waveform, peak current 0.62 mA, administered for 6 minutes per session with participants seated, eyes closed, and listening to relaxing meditative music.

Also known as: GVS
Active GVSSham GVS

Eligibility Criteria

Age18 Years - 49 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Аge between 18 and 49 years
  • Absence of dermatological conditions (e.g., eczema, psoriasis) or open wounds in the electrode placement area (mastoid region)
  • No metallic or electronic implants (e.g., pacemakers, cochlear implants)
  • No history of neurological, psychiatric, or cardiovascular disorders
  • Not currently pregnant
  • Employment or activities not involving the operation of vehicles or hazardous machinery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

JSC "Kazakhtelecom"

Almaty, 050004, Kazakhstan

Location

Al-Farabi Kazakh National University

Almaty, 050040, Kazakhstan

Location

Related Publications (11)

  • Kollmansperger S, Decker J, Berkes S, Jahn K, Wuehr M. A mobile electrical stimulator for therapeutic modulation of the vestibular system - design, safety, and functionality. Front Neurol. 2024 Nov 13;15:1502204. doi: 10.3389/fneur.2024.1502204. eCollection 2024.

    PMID: 39606706BACKGROUND
  • Pliego A, Vega R, Gomez R, Reyes-Lagos JJ, Soto E. A transient decrease in heart rate with unilateral and bilateral galvanic vestibular stimulation in healthy humans. Eur J Neurosci. 2021 Jul;54(2):4670-4681. doi: 10.1111/ejn.15338. Epub 2021 Jun 22.

    PMID: 34076918BACKGROUND
  • Thayer JF, Lane RD. A model of neurovisceral integration in emotion regulation and dysregulation. J Affect Disord. 2000 Dec;61(3):201-16. doi: 10.1016/s0165-0327(00)00338-4.

    PMID: 11163422BACKGROUND
  • Matsugi A, Nagino K, Shiozaki T, Okada Y, Mori N, Nakamura J, Douchi S, Oku K, Nagano K, Tamaru Y. No Impact of Stochastic Galvanic Vestibular Stimulation on Arterial Pressure and Heart Rate Variability in the Elderly Population. Front Hum Neurosci. 2021 Feb 17;15:646127. doi: 10.3389/fnhum.2021.646127. eCollection 2021.

    PMID: 33679355BACKGROUND
  • Yamamoto Y, Struzik ZR, Soma R, Ohashi K, Kwak S. Noisy vestibular stimulation improves autonomic and motor responsiveness in central neurodegenerative disorders. Ann Neurol. 2005 Aug;58(2):175-81. doi: 10.1002/ana.20574.

    PMID: 16049932BACKGROUND
  • Craig AD. How do you feel--now? The anterior insula and human awareness. Nat Rev Neurosci. 2009 Jan;10(1):59-70. doi: 10.1038/nrn2555.

    PMID: 19096369BACKGROUND
  • Shaffer F, Ginsberg JP. An Overview of Heart Rate Variability Metrics and Norms. Front Public Health. 2017 Sep 28;5:258. doi: 10.3389/fpubh.2017.00258. eCollection 2017.

    PMID: 29034226BACKGROUND
  • Yates BJ, Bolton PS, Macefield VG. Vestibulo-sympathetic responses. Compr Physiol. 2014 Apr;4(2):851-87. doi: 10.1002/cphy.c130041.

    PMID: 24715571BACKGROUND
  • Marchand S, Langlade A, Legois Q, Severac Cauquil A. A wide-ranging review of galvanic vestibular stimulation: from its genesis to basic science and clinical applications. Exp Brain Res. 2025 Apr 27;243(5):131. doi: 10.1007/s00221-025-07079-8.

    PMID: 40289049BACKGROUND
  • Dlugaiczyk J, Gensberger KD, Straka H. Galvanic vestibular stimulation: from basic concepts to clinical applications. J Neurophysiol. 2019 Jun 1;121(6):2237-2255. doi: 10.1152/jn.00035.2019. Epub 2019 Apr 17.

    PMID: 30995162BACKGROUND
  • Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996 Mar;17(3):354-81. No abstract available.

    PMID: 8737210BACKGROUND

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 9, 2026

First Posted

July 20, 2026

Study Start

November 30, 2021

Primary Completion

May 13, 2022

Study Completion

May 13, 2022

Last Updated

July 20, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share

De-identified individual participant data that underlie the results reported in this article, including: Demographic and anthropometric data (age, sex, body mass index) Heart rate variability indices (time-domain: SDNN, mean RR intervals; frequency-domain: HFnu; nonlinear: SD1, SD2, SD2/SD1 ratio, DFA α1; geometric: Baevsky Stress Index) Psychometric questionnaire scores (PANAS, IDS-SR, GAD-7) Stimulation-related sensations ratings (dizziness, warmth, burning, itching) Data dictionaries defining all variables will be provided alongside the datasets.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
De-identified individual participant data and supporting documents will be available beginning 9 months following publication of the main results and ending 5 years after publication.
Access Criteria
Data and supporting documents will be made available upon reasonable request to the principal investigator. Requests will be reviewed to ensure appropriate use and compliance with ethical standards.

Locations